Your Messages Inbox
Your Article Summary
See Latest ArticlesA Throbbing Pain in the Head: Trastuzumab-induced Migraine
Anticancer Research, 11/06/09
Van Rooij F et al. – Trastuzumab, an epidermal growth factor receptor inhibitor, is used in the treatment of both early–stage and metastatic breast cancer. In general it is well tolerated, with a flu–like syndrome occurring frequently a few hours after administration, including symptoms such as fever, sweating, skin rash, nausea and headache. A migraineous headache however has never been described as an adverse event. Here the authors present a patient in whom a strong relationship between trastuzumab infusion and a migraineous headache syndrome was present, without evidence of metastatic disease. Treatment with corticosteroids for the infusion–related complaints resulted in significant pain relief.
Related Articles
Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09
Relevance Score: 69%
CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine
Expert Review of Neurotherapeutics, 11/12/09
Relevance Score: 68%
Controversies in migraine
Nurse Prescribing, 10/09/09
Relevance Score: 68%
Ankle-Brachial Index, a Screening for Peripheral Obstructive Arterial Disease, and Migraine – A Controlled Study
Headache: The Journal of Head and Face Pain, 10/07/09
Relevance Score: 68%
New drugs for migraine
The Journal of Headache and Pain, 10/05/09
Relevance Score: 68%
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Back Pain: How to Avoid Surgery?
British Journal of Medical Practitioners, 12/18/09
Effects of Anodal Transcranial Direct Current Stimulation on Chronic Neuropathic Pain in Patients With Multiple Sclerosis
The Journal of Pain, 12/18/09
Pharmacological Treatment of Neuropathic Facial Pain in the Dutch General Population
The Journal of Pain, 12/18/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: Results from a randomized phase II study
Palliative Medicine, 12/18/09
Pain in patients with lung cancer: Pathophysiology and treatment
Lung Cancer, 12/18/09
Smoking Status and Pain Level Among Head and Neck Cancer Patients
The Journal of Pain, 12/17/09
Today in Pharmacy...keeping you current
Receive free subspecialty "5-minute updates" via email
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: Results from a randomized phase II study
Palliative Medicine, 12/18/09
Pharmacological Treatment of Neuropathic Facial Pain in the Dutch General Population
The Journal of Pain, 12/18/09
Optimizing Epidural Fentanyl Loading Dose for Early Labor Pain
Acta Anaesthesiologica Taiwanica, 12/18/09
Article Search
Sponsor